Radcliffe Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-308,841
| Closed | -$3.12M | – | 831 |
|
|
2022
Q4 | $3.12M | Buy |
308,841
+95,242
| +45% | +$962K | 0.1% | 320 |
|
|
2022
Q3 | $2.12M | Sell |
213,599
-1
| -0% | -$10 | 0.05% | 609 |
|
|
2022
Q2 | $2.09M | Hold |
213,600
| – | – | 0.05% | 642 |
|
|
2022
Q1 | $2.09M | Buy |
213,600
+13,600
| +7% | +$133K | 0.05% | 621 |
|
|
2021
Q4 | $1.94M | Hold |
200,000
| – | – | 0.05% | 598 |
|
|
2021
Q3 | $1.95M | Hold |
200,000
| – | – | 0.06% | 489 |
|
|
2021
Q2 | $1.94M | Buy |
+200,000
| New | +$1.94M | 0.06% | 515 |
|